ERBB2 and breast cancer: In the multivariate analysis, we included variables with a p value < 0.05 and found that axillary lymph node metastasis (p < 0.0001) and MNX1 expression level (p = 0.031) were independent prognostic factors that affected HER2-positive breast cancer DFS (Table 3).